MESOMesoblast Ltd
Slide 1 of 3
Company Overview
Name
Mesoblast Ltd
52W High
$22.00
52W Low
$9.61
Market Cap
$3.8B
Dividend Yield
0%
Price/earnings
-0.0846
P/E
-0.0846
Tags
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$17.2M
Operating Revenue
$17.2M
Total Gross Profit
$-5.8M
Total Operating Income
$-82M
Net Income
$-102.1M
EV to EBITDA
$0.00
EV to Revenue
$218.95
Price to Book value
$6.36
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$39.3M
Research & Development Expense
$34.8M
Amortization Expense
$5.1M
Other Operating Expenses / (Income)
$-3.1M
Total Operating Expenses
$-76.2M
Other Income / (Expense), net
$-19.8M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Mesoblast Ltd
52W High
$22.00
52W Low
$9.61
Market Cap
$3.8B
Dividend Yield
0%
Price/earnings
-0.0846
P/E
-0.0846
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$17.2M
Operating Revenue
$17.2M
Total Gross Profit
$-5.8M
Total Operating Income
$-82M
Net Income
$-102.1M
EV to EBITDA
$0.00
EV to Revenue
$218.95
Price to Book value
$6.36
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$39.3M
Research & Development Expense
$34.8M
Amortization Expense
$5.1M
Other Operating Expenses / (Income)
$-3.1M
Total Operating Expenses
$-76.2M
Other Income / (Expense), net
$-19.8M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Silviu Itescu
Location
N/A, Australia
Exchange
Nasdaq
Website
https://mesoblast.com
Summary
Mesoblast Limited offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases.
Company Info
CEO
Silviu Itescu
Location
N/A, Australia
Exchange
Nasdaq
Website
https://mesoblast.com
Summary
Mesoblast Limited offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases.
